Wells Fargo sees relatively limited exposure to digital advertising companies outside of DoubleVerify (DV) and Reddit (RDDT) from President Trump’s executive order increasing disclosure requirements for pharma advertising. The order will likely impact ad spend negatively, with DoubleVerify and Reddit having high-single-digit exposure, the analyst tells investors in a research note. Wells says both companies have over 5% exposure to the pharmaceutical category. The firm’s industry checks suggest Meta Platforms (META) enforced new rules on its health and wellness category advertisers in early 2025, which will likely limiting any impact to the company from Trump’s order.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DV:
- DoubleVerify (DV) Reports Strong Q2 Earnings Performance
- Balanced Hold Recommendation for DoubleVerify Holdings Amid Positive Developments and Macroeconomic Uncertainties
- Balanced Outlook on DoubleVerify Holdings: Strong Q2 Performance Amidst Cautious Future Guidance
- Strategic Growth and Revenue Potential Drive Buy Rating for DoubleVerify Holdings
- DoubleVerify price target raised to $20 from $17 at Raymond James